Your email was sent successfully. Check your inbox.

An error occurred while sending the email. Please try again.

Proceed reservation?

Export
  • 1
    Online Resource
    Online Resource
    Weinheim, Germany :Wiley-VCH,
    UID:
    almafu_9959328389402883
    Format: 1 online resource
    ISBN: 9783527694396 , 3527694390 , 3527694439 , 9783527694433
    Content: The book discusses in a detailed manner various nanomaterials used for biomedical applications, including clinical applications, diagnosis and tissue engineering. After the presentation of an overview of biomedical nanomaterials, including their classification and applications, the first part of the book is devoted to biomedical nanomaterials for therapy applications. For example, polymer micelles, dendrimers, polymer-drug conjugates as well as antibody-drug conjugates are discussed with respect to their cancer drug delivery properties. The next parts discuss biomedical nanomaterials that are used for imaging, diagnosis and sensors, as well as for tissue engineering. In the final section, the safety of biomedical nanomaterials is elaborated.
    Note: Cover; Title Page; Copyright; Contents; List of Contributors; Chapter 1 Pharmacokinetics and Pharmacodynamics (PK/PD) of Bionanomaterials; 1.1 Introduction; 1.2 Commonly Utilized NMs in Pharmaceutical Research; 1.2.1 Natural NMs; 1.2.1.1 Lipid-Based NMs; 1.2.1.2 Protein-Based NMs; 1.2.1.3 Polysaccharide-Based NMs; 1.2.2 Synthetic NMs; 1.2.2.1 Diversity of Synthetic NMs in Forms; 1.2.2.2 Drug Release Behaviors; 1.2.3 Inorganic NMs; 1.2.4 Other NMs; 1.3 In vivo Biodistribution and the Evolving Targeting Principles for NMs; 1.3.1 Organ Distribution versus Cell-Specific Targeting. , 1.3.2 Targeting Delivery Strategies1.4 Processing NMs by the Biological Systems; 1.4.1 Anatomic Basis of NMs' in vivo Biodistribution Behavior; 1.4.2 Factors Affecting in vivo Biodistribution of NMs; 1.4.2.1 Size; 1.4.2.2 Zeta Potential; 1.4.2.3 Shape and Deformability; 1.4.2.4 Hydrophilicity and Hydrophobicity; 1.4.3 Metabolism and Elimination of NMs; 1.4.3.1 Common Metabolism; 1.4.3.2 Degradable versus Nondegradable NMs; 1.4.3.3 Free Drug versus Drug Encapsulated by NMs; 1.5 Rational Design of Long-Circulating NMs; 1.5.1 NMs with Optimal Physicochemical Characters. , 1.5.2 Surface Modification to Improve the Intrinsic Features of NMs1.6 Mathematic Simulation of NM-Mediated Cancer Drug Delivery; 1.6.1 Progress: From Experiment to Simulation; 1.6.2 Compartment Models for PK Assessment of NMs; 1.6.3 Physiologically Based Compartment Models; 1.6.3.1 Protocols of Building a PBPK Model for NMs; 1.6.3.2 Examples; 1.6.4 Brief Summary; 1.7 Experimental PK Data of the Applied NMs; 1.7.1 PK Data of NMs Without Drugs; 1.7.2 PK Differences Between Drugs Encapsulated by Different NMs; 1.7.3 Reciprocal Blood and Tissue PK. , 1.7.4 PK Differences Between Different Components of the Drug-NM System1.7.5 PK Variations Among Different Routes of Administration; 1.8 Perspectives; 1.8.1 Development of NMs; 1.8.2 Pharmacokinetic Study and Model Development; References; Chapter 2 Targeted Dendrimers for Cancer Diagnosis and Therapy; 2.1 Introduction; 2.2 Targeted Dendrimers for Cancer Therapy; 2.2.1 Low Molecular Weight Ligand-Modified Dendrimers; 2.2.1.1 Folic Acid-Modified Dendrimers; 2.2.1.2 Carbohydrate-Modified Dendrimers; 2.2.1.3 Biotin-Modified Dendrimers; 2.2.1.4 Riboflavin-Modified Dendrimers. , 2.2.1.5 Estrogen-Modified Dendrimers2.2.2 Macromolecular Ligand-Modified Dendrimers; 2.2.2.1 Antibody-Modified Dendrimers; 2.2.2.2 Transferrin (Tf)- and Lactoferrin (Lf)-Modified Dendrimers; 2.2.2.3 EGF- and Fibroblast Growth Factor (FGF)-Modified Dendrimers; 2.2.2.4 Peptide-Modified Dendrimers; 2.2.2.5 Aptamer-Modified Dendrimers; 2.2.2.6 Hyaluronic Acid (HA)-Modified Dendrimers; 2.2.3 Dual-Targeting Ligand-Modified Dendrimers; 2.3 Targeted Dendrimers for Cancer Diagnosis; 2.3.1 Targeted Dendrimers in CT; 2.3.2 Targeted Dendrimers in SPECT; 2.3.3 Targeted Dendrimers in MRI.
    Additional Edition: Print version: Biomedical nanomaterials. Weinheim, Germany : Wiley-VCH, 2016 ISBN 3527337989
    Additional Edition: ISBN 9783527337989
    Language: English
    Keywords: Electronic books. ; Electronic books. ; Electronic books.
    Library Location Call Number Volume/Issue/Year Availability
    BibTip Others were also interested in ...
Close ⊗
This website uses cookies and the analysis tool Matomo. Further information can be found on the KOBV privacy pages